Reduced Cardiovascular Morbi-mortality by Sildenafil in Patients With Arterial Claudication
Status:
Unknown status
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
Sildenafil has shown potential effects both on vasodilator mechanisms and as an inhibitor of
the NO/GMPc Pain activation. The investigators aim at estimating the benefit of sildenafil in
term of morbi-mortality in patients with arterial claudication on a multicenter prospective
double blind study.